| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 06/12/2003 | WO2003048158A1 Glycinamides as factor xa inhibitors |
| 06/12/2003 | WO2003048138A1 [1.2]-oxazin-3,5-diones |
| 06/12/2003 | WO2003048123A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 06/12/2003 | WO2003048122A2 Inhibitors of cytosolic phospholipase a2 |
| 06/12/2003 | WO2003048109A1 Novel glucagon antagonists |
| 06/12/2003 | WO2003048106A2 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof |
| 06/12/2003 | WO2003048101A1 Induction of apoptosis in cancer cells |
| 06/12/2003 | WO2003048081A2 Glycinamides as factor xa inhibitors |
| 06/12/2003 | WO2003047581A1 Acetylene derivatives having mglur 5 antagonistic activity |
| 06/12/2003 | WO2003047568A1 N-aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
| 06/12/2003 | WO2002017712A3 Disubstituted benzenes as insecticides |
| 06/12/2003 | US20030109718 Enantioselective transformation of alpha, beta-unsaturated aldehydes using chiral organic catalysts |
| 06/12/2003 | US20030109568 1H-indole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 06/12/2003 | US20030109559 N-(3-amino-2-hydroxy-propyl)substituted alkylamide compounds |
| 06/12/2003 | US20030109545 Their solvates and/or hydrates exhibiting an affinity and a selectivity for arginine-vasopressin V1b receptors or for both V1b and V1a receptors. |
| 06/12/2003 | US20030109533 New benzenesulphonamide compounds |
| 06/12/2003 | US20030109528 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 06/12/2003 | US20030109520 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
| 06/12/2003 | US20030109500 Compositions and methods for use in targeting vascular destruction |
| 06/12/2003 | US20030108946 Controlling protein kinase signal transduction; anticancer agents, rheumatic diseases, atherosclerosis, antidiabetic agents |
| 06/12/2003 | US20030108892 Exciplexes |
| 06/12/2003 | US20030108289 Drop-before-add optical switching and routing system employing grating-based wavelength selective |
| 06/12/2003 | US20030108275 Optical switch systems using waveguide grating-based wavelength selective switch modules |
| 06/12/2003 | US20030107798 Wavelength converter using Bragg-grating |
| 06/12/2003 | CA2469193A1 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof |
| 06/12/2003 | CA2468967A1 N-aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
| 06/12/2003 | CA2468745A1 Induction of apoptosis in cancer cells |
| 06/12/2003 | CA2467435A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 06/11/2003 | EP1317490A1 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors |
| 06/11/2003 | EP1317456A2 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
| 06/11/2003 | EP1317446A1 Oxindole derivatives |
| 06/11/2003 | EP1317430A1 (2-azabicyclo 2.2.1]hept-7-yl)methanol derivatives as nicotinic acetylcholine receptor agonists |
| 06/11/2003 | EP1317424A2 Polyamine analogues as therapeutic and diagnostic agents |
| 06/11/2003 | EP1317416A2 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 06/11/2003 | EP1317413A1 Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same |
| 06/11/2003 | EP1060161B1 Matrix metalloproteinase inhibitors |
| 06/11/2003 | EP1042289A4 Indole]naphthopyrans, preparation, compositions and (co)polymer matrices containing them, synthesis intermediates |
| 06/11/2003 | CN1423637A Novel substituted tricyclic compounds |
| 06/11/2003 | CN1423636A Method for purifying lactames |
| 06/11/2003 | CN1423630A Quaternary ammonium compounds and their use as anti-tussive agents |
| 06/11/2003 | CN1422847A Epiphysin synthesis method |
| 06/10/2003 | US6576769 Formed via contacting O-ethyl-L-tyrosine with activating reagent, then contacting with Lewis acid, and quenching with protic solvent |
| 06/10/2003 | US6576767 Method for producing condensation compounds |
| 06/10/2003 | US6576656 Such as 1-(2-diethylaminoethyl)-4-trifluoromethyl-6-carbamoyl-3-hydroxy-3-(2 -chlorophenyl)oxindole; growth hormone releaser |
| 06/10/2003 | US6576655 To produce polymers; cancer therapy |
| 06/10/2003 | US6576653 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors |
| 06/10/2003 | US6576630 Compounds and compositions as protease inhibitors |
| 06/05/2003 | WO2003045982A1 Antibiotics fki-9739 and process for producing the same |
| 06/05/2003 | WO2003045957A1 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide |
| 06/05/2003 | WO2003045956A1 Process for the preparation of 2-or-9-oxa-3, 7-diazabicyclo (3.3.1) nonanes from 2-aminomethyl-2, 3-dihydrooxazines, intermediates therefore, and processes for preparing such intermediates |
| 06/05/2003 | WO2003045921A1 Heterocyclic amide compounds as apolipoprotein b inhibitors |
| 06/05/2003 | WO2003045916A1 Process for the preparation of ramipril |
| 06/05/2003 | WO2003045915A1 Bisimide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition |
| 06/05/2003 | WO2003045914A1 Crystals of non-natural stereoisomer salts of monatin and utilization thereof |
| 06/05/2003 | WO2003045392A2 Use of n-(indolcarbonyl-)piperazine derivatives |
| 06/05/2003 | WO2002036075A3 Small molecule compositions for binding to hsp90 |
| 06/05/2003 | US20030105300 Carbocyanine dyes/bioconjugates; optical tomography; fluorescence endoscopy; treating atherosclerotic plaques and blood clots; laser detection of metastasis |
| 06/05/2003 | US20030105151 Anticancer agents; antiinflammatory agents; autoimmune diseases; rheumatic diseases |
| 06/05/2003 | US20030105138 Using carvedilol, or synergistic mixture thereof |
| 06/05/2003 | US20030105100 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 06/05/2003 | US20030105092 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 06/05/2003 | US20030105091 Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors |
| 06/05/2003 | US20030105056 Used to produce amino- modified linkers that space an oligonucleotide from a solid support |
| 06/05/2003 | CA2468716A1 Heterocyclic amide compounds as apolipoprotein b inhibitors |
| 06/05/2003 | CA2468422A1 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide |
| 06/05/2003 | CA2468380A1 Use of n-(indolecarbonyl)piperazine derivatives |
| 06/05/2003 | CA2465840A1 Process for the preparation of 2-or-9-oxa-3, 7-diazabicyclo (3.3.1) nonanes from 2-aminomethyl-2, 3-dihydrooxazines, intermediates therefore, and processes for preparing such intermediates |
| 06/04/2003 | EP1316543A1 Process for the preparation of aminocarboxylic acids |
| 06/04/2003 | EP1226120B1 Benz[f]indoles for use in the treatment of 5ht receptor related disorders |
| 06/04/2003 | EP1062217B1 Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives |
| 06/04/2003 | EP1038863B1 Substituted dimeric compounds, process for their preparation and pharmaceutical compositions thereof |
| 06/04/2003 | EP1017395A4 Method for treating premenstrual or late luteal phase syndrome |
| 06/04/2003 | EP0964849B1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity |
| 06/04/2003 | EP0938712B1 System and method for remotely grouping contents of an action history stack |
| 06/04/2003 | EP0789578B1 Multicatalytic protease inhibitors |
| 06/04/2003 | CN1422253A Carbamate caspase inhibitors and uses thereof |
| 06/04/2003 | CN1422246A Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 06/04/2003 | CN1110497C Di-or triaza-spiral [4,5] decane derivative |
| 06/03/2003 | USRE38133 Kappa agonist compounds and pharmaceutical formulations thereof |
| 06/03/2003 | US6573395 Zinc complex with a chiral ligand, such as diethylzinc((S,S)-N-N'-ethylene-bis-(1-phenylethylamine)) |
| 06/03/2003 | US6573386 Intermediates to the vasopressine V2 antagonistic compound, SR 121463 |
| 06/03/2003 | US6573345 Late transition metal pyrrolaldimine chelates, especially bidentate |
| 06/03/2003 | US6573293 Anticancer agents |
| 06/03/2003 | US6573292 Treatment of Chronic Lymphocytic Leukemia and B- cell and T-cell lymphomas are provided. These methods comprise administering to a patient in need of treatment an effective amount of certain indole and carbazole compounds, such as |
| 06/03/2003 | US6573284 Method of treating melanoma |
| 06/03/2003 | US6573278 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 06/03/2003 | US6573277 Metalloproteinase inhibitor |
| 06/03/2003 | US6573264 Heteroaryl alkyl piperazine derivatives |
| 06/03/2003 | US6573262 Compounds for treating mammals infected with HIV virus |
| 06/03/2003 | US6573252 Therapy and prevention of bony disorders; improved gastrointestinal tolerability |
| 06/03/2003 | CA2223625C Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors |
| 05/30/2003 | WO2003044877A2 Light emitting device and compounds for use therein |
| 05/30/2003 | WO2003044014A1 Indole-2-carboxamides as factor xa inhibitors |
| 05/30/2003 | WO2003044011A1 Pyrrole synthesis |
| 05/30/2003 | WO2003043985A1 Heterocyclic compounds and methods of use |
| 05/30/2003 | WO2003043975A1 Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease |
| 05/30/2003 | WO2003043619A1 New use for the treatment of gastroesophageal reflux disease |
| 05/30/2003 | WO2003043618A2 Amino diols useful in the treatment of alzheimer's disease |
| 05/30/2003 | WO2003043578A2 Modulators of rho c activity |
| 05/30/2003 | WO2003010141A3 Hepatitis c virus polymerase inhibitors with a heterobicyclic structure |